Sakura Kirino

Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease

Nobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi et al. · Journal of Gastroenterology and Hepatology · 2021 · 72 citations

Longitudinal association of magnetic resonance elastography‐associated liver stiffness with complications and mortality

Mayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki et al. · Alimentary Pharmacology & Therapeutics · 2021 · 64 citations · Full text

Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate

Shun Kaneko, Masayuki Kurosaki, Nobuharu Tamaki et al. · Journal of Gastroenterology and Hepatology · 2019 · 62 citations

Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma

Sakura Kirino, Kaoru Tsuchiya, Masayuki Kurosaki et al. · PLoS ONE · 2020 · 61 citations · Full text

Hepatology, Lenvatinib Therapy, Medicine +15

Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice

Yuka Hayakawa, Kaoru Tsuchiya, Masayuki Kurosaki et al. · Investigational New Drugs · 2021 · 56 citations

Real-world Practice, Hepatology, Medicine +8